Inactive Total Small Business Set-Aside (FAR 19.5)

The U.S. Food and Drug Administration (FDA), National Center for Toxicological Research (NCTR) requires animal care and technical procedures services for the Center’s animal research program. The soli... The U.S. Food and Drug Administration (FDA), National Center for Toxicological Research (NCTR) requires animal care and technical procedures services for the Center’s animal research program. The solicitation 75F40123R00001 has been amended to (1) answer contractor-posed questions and (2) provide revised solicitation and attachments based on these questions and answers. Please see the following attachments: 75F40123R00001 Amendment 01 - Q and A; FDA 7540123R00001 Amendment 01 (solicitation); Attachment 1 - PWS Amend 01; Attachment 2 - Pricing Worksheet Labor Categories Amend 01; Attachment 7 - Sample Client Authorization Letter Amend 01.

Inactive Total Small Business Set-Aside (FAR 19.5)

The U.S. Food and Drug Administration (FDA), National Center for Toxicological Research (NCTR) requires support services for the Center’s animal research program, to include at a minimum the provision... The U.S. Food and Drug Administration (FDA), National Center for Toxicological Research (NCTR) requires support services for the Center’s animal research program, to include at a minimum the provision of superlative care to all research animals, sanitation of all animal care and diet preparation/formulation facilities, and the provision of protocol-specified technical procedures support; the requirement also includes those ancillary tasks necessary to the accomplishment of these services, i.e., quality control, occupational safety and health measures, inventory control, equipment maintenance, development and maintenance of standard operating procedures, and a comprehensive training and cross-training program. These services are of paramount importance to the Center as the essential elements of the FDA's research mission can be accomplished only through animal research. Animal-based research projects are highly-regulated and demand nonpareil execution. The North American Industry Classification System (NAICS) code for this acquisition is 541714 - Research and Development in Biotechnology (except Nanobiotechnology); the corresponding Small Business Size Standard is 1,000 employees. This requirement shall be solicited as a 100% set-aside for small business concerns. All responsible small business sources may submit a proposal. FDA solicitation number 75F40123R00001 is expected to be released on or about February 10, 2023, with a closing date of thirty (30) calendar days subsequent to posting. The anticipated award date is on or about May 25, 2023. Any resultant contract is expected to be a Labor Hour (LH) contract, and will consist of a base period plus up to four (4) 1-year option periods. It is the contractor's responsibility to monitor SAM.gov/contract opportunities for further information relevant to this solicitation. Note: The Response Date and Time represents the expected release date for the solicitation, and serves only as a placeholder field required for publication of this Notice.